New thread. Changed the title.
I seem to have too much time on my hands, and I keep thinking about the potential deals in Asia, specifically China. The company has openly stated they are in discussions. The questions I am asking myself;
x if they are in discussions, could we expect a deal before Phase 3 results?
x if so, and given they will have exclusive use of the future data generated from the Phase 3 trial (without the $100m trial costs), should the upfront amount be +$100m? The Chinese mark would be well over double the size which would counter the possibility that the revenue generated may not be as great as in the USA. Say a nil all draw there.
x if a significant upfront, then at today's prices Neuren would have an effective EV of nearly $0. Crazy.
Maybe I should stop thinking and just be patient. I think we are very, very close to something huge.
PS; my sentiment is buy but I won't be buying as I have a very full basket. Just for transparency.
China deal?
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5901 | $19.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 3262 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |